BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38488487)

  • 1. Impact of major hepatectomy on recurrence after resection of hepatocellular carcinoma at CNLC Ib stage: a propensity score matching study.
    Jiang K; Li J; Liu Z; Chen M; Cai W; Liu L; Yin D
    Int J Surg; 2024 Jun; ():. PubMed ID: 38913430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience.
    Zhang S; Yang G; Song R; Wang W; Meng F; Yin D; Wang J; Zhang S; Cai W; Liu Y; Luo D; Wang J; Liu L
    Ther Adv Med Oncol; 2024; 16():17588359241258394. PubMed ID: 38882444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison.
    Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos R; Brown RS; Ibrahim S; Fortune BE; Talenfeld AD; Madoff DC; Johnson MS; Sedrakyan A
    AJR Am J Roentgenol; 2024 Jun; ():. PubMed ID: 38899842
    [No Abstract]   [Full Text] [Related]  

  • 4. Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study.
    Abdelmalak J; Strasser SI; Ngu NL; Dennis C; Sinclair M; Majumdar A; Collins K; Bateman K; Dev A; Abasszade JH; Valaydon Z; Saitta D; Gazelakis K; Byers S; Holmes J; Thompson AJ; Pandiaraja D; Bollipo S; Sharma S; Joseph M; Sawhney R; Nicoll A; Batt N; Tang MJ; Riordan S; Hannah N; Haridy J; Sood S; Lam E; Greenhill E; Lubel J; Kemp W; Majeed A; Zalcberg J; Roberts SK
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation Analysis.
    Wang J; Im Y; Wang R; Ma S
    Life (Basel); 2024 May; 14(6):. PubMed ID: 38929645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
    Gastroenterol Res Pract; 2013; 2013():430438. PubMed ID: 23710167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of long-term survival outcomes between surgical resection and radiofrequency ablation in patients with single hepatocellular carcinoma ≤ 2 cm (BCLC very early stage).
    Yin Z; Jin H; Ma T; Zhou Y; Yu M; Jian Z
    Int J Surg; 2018 Aug; 56():61-67. PubMed ID: 29723677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study.
    Yang B; Xi X; Yu H; Jiang H; Liang Z; Smayi A; Wu B; Yang Y
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2030. PubMed ID: 38488487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study.
    Hsiao CY; Hu RH; Ho CM; Wu YM; Lee PH; Ho MC
    Am J Surg; 2020 Oct; 220(4):958-964. PubMed ID: 32247523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: a systematic review and meta-analysis.
    Gadallah EA; Elkomos BE; Khalil A; Fawzy FS; Abdelaal A
    BMC Surg; 2023 Jan; 23(1):2. PubMed ID: 36600282
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.